+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Gastric Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Gastric Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Cancer Immunotherapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Cancer Biological Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Biological Therapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
From
Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
From
PD-1/PD-L1 Checkpoint Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

PD-1/PD-L1 Checkpoint Inhibitors Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
Immuno-Oncology Service Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Service Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Immune Checkpoint Proteins Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immune Checkpoint Proteins Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Throat Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Throat Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 267 Pages
  • Global
From
Oral Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 182 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • September 2026
  • 282 Pages
  • Global
From
Nasopharynx Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Nasopharynx Cancer Market - Global Strategic Business Report

  • Report
  • September 2026
  • 287 Pages
  • Global
From
Oncolytic Virotherapy Market - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virotherapy Market - Global Strategic Business Report

  • Report
  • September 2026
  • 243 Pages
  • Global
From
Gastric Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer Market - Global Strategic Business Report

  • Report
  • September 2026
  • 582 Pages
  • Global
From
Metastatic Cancer Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs Market - Global Strategic Business Report

  • Report
  • September 2026
  • 377 Pages
  • Global
From
From
From
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more